Why the study?
Inherited hypertrophic cardiomyopathy is a fatal disease with genetic factors playing an important role, and pedigree analysis is an effective method to identify causative genetic defects.
The MYH7 c.3134G>A (p.Arg1045His) variation co-segregates with hypertrophic cardiomyopathy in a Chinese pedigree and is classified as likely pathogenic.
Answers are grounded in this paper and cite their sources.
Pedigree sequencing identifies candidate HCM variant; leaves open causal role and generalizability.
Objective: Inherited hypertrophic cardiomyopathy (HCM) is s a fatal disease that damages heart function and may cause the heart to stop beating suddenly. The genetic factors play an important role in HCM. Pedigree analysis is a good way to identify the genetic defects that cause disease. Methods: A HCM pedigree was found in Yunnan of China. Whole-exome sequencings were performed for finding the genetic variant of HCM. Another 30 HCM patients and 200 health controls were also used to investigate the frequency of variation by TaqMan-MGB method. Results: The variation NM_000257.4:c.3134G>A (NP_000248.2:p.Arg1045His, rs397516178, short as c.3134G>A) was found to co-segregate with the symptoms of HCM. Meanwhile, the variation was not found in 200 controls. After genotyping the variation in 30 HCM patients, one patient carried the variation and had a family history. Conclusion: Our findings support that this variation may be closely related to the occurrence of the disease. According the ACMG guideline, the c. 3134G>A should be classified as " Likely pathogenic".
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2020) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: